Physician profile
Hall T Mcgee
NPI 1215145321
$1,353.46
in general payments reported to CMS, 2019-2025
16 companies · $386 in 2025
The $386 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $145 · 2021: $24.77 · 2022: $52.56 · 2023: $330 · 2024: $260 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.36 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $428.70 | 2020-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Biotissue Holdings INC. | $158.71 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $137.13 | 2019-2025 | Eylea Hd |
| Bausch & Lomb Americas INC. | $121.40 | 2023-2024 | Miebo, Vyzulta |
| Oyster Point Pharma, INC. | $74.36 | 2022-2023 | Tyrvaya |
| Tearlab Corp | $67.02 | 2024 | Scoutpro Osmolarity System |
| Sun Pharmaceutical Industries INC. | $55.46 | 2022-2023 | Cequa |
| Apellis Pharmaceuticals, INC. | $55.03 | 2024-2025 | Syfovre |
| Dompe US, INC. | $50.05 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.40 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $39.63 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $37.35 | 2019 | |
| Genentech USA, INC. | $30.27 | 2025 | Vabysmo |
| Kala Pharmaceuticals, INC. | $24.77 | 2021 | |
| Quidel Corporation | $16.79 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $15.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hall Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.